AKESOgen Growth, Revenue, Number of Employees and Funding

Overview

Location:
Atlanta, GA USA
Total Funding:N/A
Industry:Biotech
Founded:2010
Lead Investor(s):N/A
Press

City Ranking

Industry Ranking

State Ranking

Estimated Revenue & Financials

  • AKESOgen's estimated revenue is currently $5.7M per year.
  • AKESOgen's estimated revenue per employee is $143375

Employee Data

  • AKESOgen has 40 Employees.
  • AKESOgen grew their employee count by 25% last year.
  • AKESOgen currently has 1 job openings.

Executive Contacts

NameTitle
Mark BouzykCo-Founder & Chief Scientific Officer
Maria MikkelsonVice President Information Technology
Kevin RobsonDirector Of Business Development
Lauren McGoldrickVice President of Project Management
Rachel CrossenSenior Director, Business Development, Genomic Services
Robert BoisjoliChief Executive Officer /founder
Gabriela Oprea-lliesLaboratory Medical Director
Barbara Glazer Director, Compliance & Clinical Trial Project Management.

What Is AKESOgen?

AKESOgen is a biomarker, genomics and pharmacogenomics CRO company that services the academic, pharmaceutical, biotechnology and agricultural sectors. The company is based in Atlanta, GA, USA. AKESOgen performs biomarker profiling and genomics services (e.g. next generation sequencing and genotyping) utilizing different types of markers (e.g. DNA, mRNA, miRNA, methylation) for the R&D market. AKESOgen establishes and validates biomarkers in the Clinical Trials arena. AKESOgen has expertise in Biobanking.

keywords:Biotechnology,Healthcare,Pharmaceuticals

40

Number of Employees

$5.7M

Revenue (est)

1

Current Jobs

25%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Omni Internatio...
$5.9M4117%
Axion BioSystem...
$9.5M658%
AKESOgen
$5.7M4025%
Omega Bio-tek
$5.4M379%
MiMedx
$111.9M773-19%$112M

AKESOgen News

02/13/2019 - RenalytixAI and AKESOgen In Joint Venture Partnership for ...

NEW YORK, Feb. 13, 2019 /PRNewswire/ -- RenalytixAI (AIM: RENX), a developer of artificial intelligence-enabled diagnostics for kidney ...

02/13/2019 - Renalytix AI Partners With AKESOgen To Expand Pharma ...

LONDON (Alliance News) - Renalytix AI PLC on Wednesday said it has entered into a partnership agreement with laboratory facility provider ...

02/18/2019 - RenalytixAI signs agreement for lab services

“AKESOgen brings a state-of-the-art CLIA-certified and CAP-accredited laboratory facility that enables RenalytixAI to immediately scale ...